Locally aggressive and multifocal phosphaturic mesenchymal tumors

two unusual cases of tumor-induced osteomalacia

Meghan Higley, Brooke Beckett, Sandra Schmahmann, Elizabeth Dacey, Erik Foss

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Tumor-induced osteomalacia (TIO) has long been recognized as a clinical paraneoplastic syndrome. The identification of a unique histopathologic entity, the phosphaturic mesenchymal tumor (PMT), as a distinct etiology for TIO has been a more recent discovery. The majority of published cases describe a solitary, non-aggressive appearing soft tissue or osseous lesions in patients with osteomalacia; aggressive appearing or multifocal lesions appear to be exceedingly rare. These tumors characteristically secrete fibroblast growth factor 23 (FGF23). Elevated serum levels of FGF23 result in phosphate wasting and osteomalacia. In the majority of cases, laboratory abnormalities and clinical signs and symptoms of osteomalacia precede identification of the causative lesion by years. Following diagnosis, complete resection with wide margins to prevent local recurrence is most often curative. Imaging characteristics of PMT are diverse and remain incompletely defined, as the majority of previous publications are outside of the radiologic literature. We present multiple imaging modalities in two cases of patients with debilitating osteomalacia and unusual appearing PMTs: one with a locally aggressive lesion leading to pathologic fracture, the second presenting with exceedingly rare multifocal PMT.

Original languageEnglish (US)
Pages (from-to)1825-1831
Number of pages7
JournalSkeletal Radiology
Volume44
Issue number12
DOIs
StatePublished - Sep 4 2015

Fingerprint

Osteomalacia
Neoplasms
Paraneoplastic Syndromes
Spontaneous Fractures
Signs and Symptoms
Phosphates
Recurrence
Oncogenic osteomalacia
Serum
fibroblast growth factor 23

Keywords

  • Fibroblast growth factor 23
  • Oncogenic osteomalacia
  • Phosphaturic mesenchymal tumor
  • Tumor-induced osteomalacia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Locally aggressive and multifocal phosphaturic mesenchymal tumors : two unusual cases of tumor-induced osteomalacia. / Higley, Meghan; Beckett, Brooke; Schmahmann, Sandra; Dacey, Elizabeth; Foss, Erik.

In: Skeletal Radiology, Vol. 44, No. 12, 04.09.2015, p. 1825-1831.

Research output: Contribution to journalArticle

@article{1b966ce1f8804c8dbe968761e8ded0e6,
title = "Locally aggressive and multifocal phosphaturic mesenchymal tumors: two unusual cases of tumor-induced osteomalacia",
abstract = "Tumor-induced osteomalacia (TIO) has long been recognized as a clinical paraneoplastic syndrome. The identification of a unique histopathologic entity, the phosphaturic mesenchymal tumor (PMT), as a distinct etiology for TIO has been a more recent discovery. The majority of published cases describe a solitary, non-aggressive appearing soft tissue or osseous lesions in patients with osteomalacia; aggressive appearing or multifocal lesions appear to be exceedingly rare. These tumors characteristically secrete fibroblast growth factor 23 (FGF23). Elevated serum levels of FGF23 result in phosphate wasting and osteomalacia. In the majority of cases, laboratory abnormalities and clinical signs and symptoms of osteomalacia precede identification of the causative lesion by years. Following diagnosis, complete resection with wide margins to prevent local recurrence is most often curative. Imaging characteristics of PMT are diverse and remain incompletely defined, as the majority of previous publications are outside of the radiologic literature. We present multiple imaging modalities in two cases of patients with debilitating osteomalacia and unusual appearing PMTs: one with a locally aggressive lesion leading to pathologic fracture, the second presenting with exceedingly rare multifocal PMT.",
keywords = "Fibroblast growth factor 23, Oncogenic osteomalacia, Phosphaturic mesenchymal tumor, Tumor-induced osteomalacia",
author = "Meghan Higley and Brooke Beckett and Sandra Schmahmann and Elizabeth Dacey and Erik Foss",
year = "2015",
month = "9",
day = "4",
doi = "10.1007/s00256-015-2246-x",
language = "English (US)",
volume = "44",
pages = "1825--1831",
journal = "Skeletal Radiology",
issn = "0364-2348",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Locally aggressive and multifocal phosphaturic mesenchymal tumors

T2 - two unusual cases of tumor-induced osteomalacia

AU - Higley, Meghan

AU - Beckett, Brooke

AU - Schmahmann, Sandra

AU - Dacey, Elizabeth

AU - Foss, Erik

PY - 2015/9/4

Y1 - 2015/9/4

N2 - Tumor-induced osteomalacia (TIO) has long been recognized as a clinical paraneoplastic syndrome. The identification of a unique histopathologic entity, the phosphaturic mesenchymal tumor (PMT), as a distinct etiology for TIO has been a more recent discovery. The majority of published cases describe a solitary, non-aggressive appearing soft tissue or osseous lesions in patients with osteomalacia; aggressive appearing or multifocal lesions appear to be exceedingly rare. These tumors characteristically secrete fibroblast growth factor 23 (FGF23). Elevated serum levels of FGF23 result in phosphate wasting and osteomalacia. In the majority of cases, laboratory abnormalities and clinical signs and symptoms of osteomalacia precede identification of the causative lesion by years. Following diagnosis, complete resection with wide margins to prevent local recurrence is most often curative. Imaging characteristics of PMT are diverse and remain incompletely defined, as the majority of previous publications are outside of the radiologic literature. We present multiple imaging modalities in two cases of patients with debilitating osteomalacia and unusual appearing PMTs: one with a locally aggressive lesion leading to pathologic fracture, the second presenting with exceedingly rare multifocal PMT.

AB - Tumor-induced osteomalacia (TIO) has long been recognized as a clinical paraneoplastic syndrome. The identification of a unique histopathologic entity, the phosphaturic mesenchymal tumor (PMT), as a distinct etiology for TIO has been a more recent discovery. The majority of published cases describe a solitary, non-aggressive appearing soft tissue or osseous lesions in patients with osteomalacia; aggressive appearing or multifocal lesions appear to be exceedingly rare. These tumors characteristically secrete fibroblast growth factor 23 (FGF23). Elevated serum levels of FGF23 result in phosphate wasting and osteomalacia. In the majority of cases, laboratory abnormalities and clinical signs and symptoms of osteomalacia precede identification of the causative lesion by years. Following diagnosis, complete resection with wide margins to prevent local recurrence is most often curative. Imaging characteristics of PMT are diverse and remain incompletely defined, as the majority of previous publications are outside of the radiologic literature. We present multiple imaging modalities in two cases of patients with debilitating osteomalacia and unusual appearing PMTs: one with a locally aggressive lesion leading to pathologic fracture, the second presenting with exceedingly rare multifocal PMT.

KW - Fibroblast growth factor 23

KW - Oncogenic osteomalacia

KW - Phosphaturic mesenchymal tumor

KW - Tumor-induced osteomalacia

UR - http://www.scopus.com/inward/record.url?scp=84944351928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944351928&partnerID=8YFLogxK

U2 - 10.1007/s00256-015-2246-x

DO - 10.1007/s00256-015-2246-x

M3 - Article

VL - 44

SP - 1825

EP - 1831

JO - Skeletal Radiology

JF - Skeletal Radiology

SN - 0364-2348

IS - 12

ER -